Dose-escalation Study of Safety of PBCAR19B in Participants With CD19-expressing Malignancies
Clinical trial NCT04649112 · COMPLETED
Trial details
- NCT number
- NCT04649112
- Sponsor
- Precision BioSciences, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-16
- Primary completion
- 2022-12-22
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.